Search company, investor...

Compare Chimerix vs WellAware Systems

Customers evaluate the quality of Chimerix's products using the following success metrics.

Overview

Chimerix Logo

Chimerix is 22 yrs old and is based in United States.

Chimerix is developing antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. Based on lipid conjugate technology, the company's two clinical stage compounds have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs. CMX001 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent cidofovir-diphosphate. Its broad spectrum activity against double-stranded DNA (dsDNA) viruses without the myelotoxicity and nephrotoxicity of current agents has the potential to improve outcomes for immunosuppressed patients. Chimerix's second clinical-stage antiviral compound, CMX157 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent tenofovir-diphosphate. It has the potential to directly address several limitations of current HIV and HBV therapies. Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, influenza, malaria and other global public health needs. In April 2013, Chimerix went public with a valuation of $341 million.

WellAware Systems is 24 yrs old and is based in United States.

WellAware Systems is a provider in advanced remote patient monitoring systems for senior care providers. The company's solutions deliver the tools for early interventions into emergent conditions, reduced hospitalizations and improved quality and cost of care.

Founded Year

Country

United States
United States

Demo Video

Demo not available because Chimerix has not claimed their profile.

Work for Chimerix? Show off your product.

Demo not available because WellAware Systems has not claimed their profile.

Work for WellAware Systems? Show off your product.

Leadership

Kevin Anderson (Founder)

See all 5 people

Teresa DiMarco (Chief Executive Officer)

See all 5 people

Funding

Chimerix last raised $102.48M on 4/11/2013.

Total Raised

$98.3M

Latest Valuation

Investors

Sanderling Ventures, Asset Management Ventures

See all 5 investors

Healthsense, .406 Ventures

See all 3 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Chimerix has not claimed their profile.

Work for Chimerix? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Chimerix?

Claim your profile now.

Information not available because WellAware Systems has not claimed their profile.

Work for WellAware Systems? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for WellAware Systems?

Claim your profile now.

Expert Collections

T

Telehealth

2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.